BlackRock Investment Management, LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 37 filers reported holding CANCER GENETICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$3,000
-25.0%
2,0860.0%0.00%
Q3 2016$4,0000.0%2,0860.0%0.00%
Q2 2016$4,0000.0%2,086
+46.5%
0.00%
Q1 2016$4,000
+33.3%
1,424
+35.9%
0.00%
Q4 2015$3,000
-62.5%
1,0480.0%0.00%
Q3 2015$8,000
-33.3%
1,0480.0%0.00%
Q2 2015$12,000
+50.0%
1,0480.0%0.00%
Q1 2015$8,000
+14.3%
1,048
-4.1%
0.00%
Q4 2014$7,000
-30.0%
1,0930.0%0.00%
Q3 2014$10,000
-9.1%
1,093
+10.0%
0.00%
Q2 2014$11,0009940.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders